Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Laboratory Corporation of America Acquires Myriad Genetics' Prenatal Health Business
Acquiring Company
Laboratory Corporation Of America
Acquired Company
Myriad Genetics
BurlingtonDescription
On October 19, 2026, Laboratory Corporation of America entered into an Asset Purchase Agreement to acquire certain assets of Myriad Genetics' prenatal health business. The transaction includes a cash payment of $210 million, plus inventory value at closing. This acquisition is expected to enhance LabCorp's capabilities in prenatal testing services.
Fundz sees it the moment Laboratory Corporation Of America makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Myriad Genetics?
Myriad Genetics was acquired by Laboratory Corporation Of America, based in Burlington. The deal was reported on October 20, 2026. Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Laboratory Corporation Of America is publicly traded (LH) and operates in Biotechnology.
When did Laboratory Corporation Of America acquire Myriad Genetics?
Laboratory Corporation Of America's acquisition of Myriad Genetics was reported on October 20, 2026. On October 19, 2026, Laboratory Corporation of America entered into an Asset Purchase Agreement to acquire certain assets of Myriad Genetics' prenatal health business. The transaction includes a cash payment of $210 million, plus inventory value at closing. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Myriad Genetics do?
Myriad Genetics is the company acquired in this transaction. It is privately held, and is based in Salt Lake City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.